In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Flunitrazepam Drug Master File in Korea (Flunitrazepam KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Flunitrazepam. The MFDS reviews the Flunitrazepam KDMF as part of the drug registration process and uses the information provided in the Flunitrazepam KDMF to evaluate the safety and efficacy of the drug.
After submitting a Flunitrazepam KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Flunitrazepam API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Flunitrazepam suppliers with KDMF on PharmaCompass.